Clinical Trials News

MIAMI & NEW YORK--(BUSINESS WIRE)--NYU Langone Health, one of the nation’s premier academic health systems and ranked No.1 in the nation for quality by Vizient, Inc., and OpenEvidence, the most popular AI for doctors in the United States, today announced a collaboration to bring OpenEvidence directly into NYU Langone’s Epic electronic health record (EHR), with Patient Aware Clinical Intelligence. Clinicians across NYU Langone will now be able to ask complex clinical questions in natural languag...

SEOUL, South Korea--(BUSINESS WIRE)--BioCentury today announced that the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) will serve as Regional Host Chair of the 6th BioCentury-BayHelix East-West Biopharma Summit, taking place March 15-17, 2027, at the Conrad Seoul in South Korea. Presented by BioCentury, BayHelix, and Insights Partner McKinsey & Company, the East-West Biopharma Summit returns to Seoul for the second time to continue the debate on Asia’s Arc of Innovati...

NAARDEN, Netherlands & WALTHAM, Mass. & BARCELONA, Spain--(BUSINESS WIRE)--Prilenia Therapeutics B.V. and Ferreri today announced the publication online, on October 22, 2026, of a new manuscript, in Neurology®, the medical journal of the American Academy of Neurology, presenting a post hoc analysis providing Phase 3 clinical trial evidence of the association between exposure to antidopaminergic medications (ADMs) and clinical outcome measures  in Huntington’s disease (HD) . The manuscript, "Ant...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--First participant has been dosed in LTZ's Phase 1/1b clinical study evaluating LTZ-232 in patients with mCRC and other solid tumors....

BALTIMORE--(BUSINESS WIRE)--Real Time Medical Systems (Real Time), the industry-leading, KLAS Rated, HITRUST r2 Certified, and SOC 2 Compliant post-acute care analytics solution, announced today its participation at the 2026 Fall Managed Care Forum, taking place October 29–30, 2026, in Las Vegas, NV. Joining healthcare executives from the American Association of Integrated Healthcare Delivery Systems (AAIHDS), the American Association of Managed Care Nurses (AAMCN), and the NAMCP Medical Directo...

SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced it received Frost & Sullivan’s 2026 North American Technology Innovation Leadership Recognition for AI-powered breast cancer risk stratification. The recognition highlights Artera’s approach to translating multimodal AI and clinical evidence into personalized cancer risk insights. ArteraAI Breast uses digitized routine pathology ima...

NEW YORK--(BUSINESS WIRE)--One-Year Follow-up Study Confirms QuantalX’s Delphi-MD Measurements Predict Sustained Response to Ventriculoperitoneal Shunting in NPH...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Metaphore Biotechnologies (“Metaphore”), a Flagship Pioneering company developing antibody medicines designed for the dynamic biology of complex disease, today announced the appointment of Frank D’Amelio and Pascal Deschatelets, Ph.D., as independent directors to the Company’s Board. As Metaphore prepares for clinical development, their appointments bring substantial scientific and business leadership to translating the Company’s platform into new categories of...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter ended September 30, 2026, and reviewed recent business highlights. “Our third quarter results reflect the continued growth of our TTR franchise and advancement of key programs with the potential for transformative patient impact,” said Yvonne Greenstreet, M.D., Chief Executive Officer of Alnylam. “As we co...

LONDON--(BUSINESS WIRE)--AviadoBio Presents Preclinical Data Validating the vMiX™ Platform for AVB-406 in Alzheimer’s Disease and for AVB-SNCA in Parkinson’s Disease at ESGCT...